Andere Sprachen BAR1 LIFE Australian S.E.

Aktien

BD1

Schlusskurs Australian S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^AUD	-.--%		-.--%	-.--%

15.04.	Befürchtung einer Eskalation des Nahostkonflikts dämpft Appetit auf australische Aktien	MT
23.02.	Inoviq's Test erkennt 19% mehr Brustkrebs als der Marktführer	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test	19.04.
Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares	15.04.
INOVIQ Signs Supply, Distribution Agreement with Promega; Shares Surge 18%	15.04.
Inoviq's Test Detects 19% More Breast Cancers Than Market Leader	23.02.
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	22.02.
Inoviq Appoints Chair Elect; Shares Climb 13%	11.10.23
Inoviq Signs Deal for Use of Biomarker Capture Product in the US	05.09.23
INOVIQ Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	30.08.23
INOVIQ AND PROMEGA ANNOUNCE GLOBAL JOINT MARKETING AGREEMENT FOR EXO-NET EXOSOME ISOLATION AND NUCLEIC ACID PURIFICATION SOLUTIONS	07.07.23
INOVIQ Limited and Promega Corporation Announce Global Joint Marketing Agreement for EXO-NET Exosome Isolation and Nucleic Acid Purification Solutions	06.07.23
Inoviq Signs Global Marketing Deal for Exosome Technology	06.07.23
Inoviq Limited Announces Clinical Validation Study for Subb2m/Ca15-3 Breast Cancer Test	27.06.23
Inoviq Confirms Efficacy of Breast Cancer Test	27.06.23
INOVIQ Limited to Present New Exo-NET Data at ISEV Annual Meeting	19.04.23
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23.02.23
INOVIQ Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23.02.23
Inoviq's Breast Cancer Diagnostic Test Outdoes Commercial Test in Independent Study	08.02.23
INOVIQ Limited Announces Positive Results for SubB2M Breast Cancer Test	08.02.23
INOVIQ Ltd Announces Resignation of Professor Allan Cripps AO as Director	13.12.22
INOVIQ's Ovarian Cancer Detection Kits Up to 90% Accurate, Study Says	13.12.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BAR1 LIFE Australian S.E.

Aktien

BD1

BD1

Andere Sprachen

Filter